SCHEMBL31346185

SCHEMBL31346185

CC(C)(C)OC(=O)N1CC[C@H]([C@H](Cc2cccc(C[C@H](C(=O)O)[C@H]3CCN(C(=O)OC(C)(C)C)C3)c2)C(=O)O)C1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 7/20 0.54
JAK2 O60674 1/20 0.49
JAK1 P23458 1/20 0.49
USP30 Q70CQ3 2/20 0.48
DPP4 P27487 1/20 0.47
STS P08842 1/20 0.47
YAP1 P46937 1/20 0.46
TACR1 P25103 1/20 0.45
MMP1 P03956 1/20 0.44
MMP13 P45452 1/20 0.44
KDM4E B2RXH2 1/20 0.44
PKM P14618 1/20 0.44
MMP9 P14780 1/20 0.44
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25957732 0.95 GPR119 (0.50) GPR119JAK2JAK1USP30DPP4
SCHEMBL25339536 0.95 GPR119 (0.52) GPR119JAK2JAK1USP30DPP4
SCHEMBL25958866 0.95 GPR119 (0.52) GPR119JAK2JAK1USP30DPP4
SCHEMBL31599049 0.95 GPR119 (0.52) GPR119JAK2JAK1USP30DPP4
SCHEMBL31291130 0.94 GPR119 (0.49) GPR119JAK2JAK1USP30DPP4
SCHEMBL31291137 0.94 GPR119 (0.49) GPR119JAK2JAK1USP30DPP4
SCHEMBL22750432 0.93 GPR119 (0.59) GPR119JAK2JAK1USP30STS
SCHEMBL22750429 0.93 GPR119 (0.59) GPR119JAK2JAK1USP30STS
SCHEMBL22750434 0.93 GPR119 (0.59) GPR119JAK2JAK1USP30STS
SCHEMBL23751448 0.93 GPR119 (0.59) GPR119JAK2JAK1USP30STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746968-A1 PYRROLIDINE COMPOUNDS LP(A) LOWERING ACTIVITY Eli Lilly and Company (US) 2026-05-27 EP disclosed
WO-2025024216-A1 PYRROLIDINE COMPOUNDS Lp(a) LOWERING ACTIVITY ELI LILLY AND COMPANY (US) 2025-01-30 WO disclosed